US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.814
  • +0.126+18.23%
Close Nov 20 16:00 ET
  • 0.800
  • -0.014-1.73%
Pre 06:05 ET
138.96MMarket Cap-3875P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Seres Therapeutics Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
25.83M
0
-25.83M
Miss Est.
+8233.33%
--
-100.00%
EPS
-0.08
0.58
+0.66
Beat Est.
+78.94%
+256.76%
+844.54%
Analyst Rating
Buy

Nov 14, 2024

Seres Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500M--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 25.833M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500M--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 25.833M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--

Unlock Free Earnings Estimates

Seres Therapeutics Earnings Reports

  • Seres Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 10:33 ET

  • Seres Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 10:42 ET

  • Seres Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 10:03 ET

  • Seres Therapeutics | 10-K: FY2023 Annual Report

    Mar 5 10:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Buy

    • Buy

      60.00%

    • Hold

      20.00%

    • Sell

      20.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.59%